tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Balance Sheet

Compare
185 Followers

SAB Biotherapeutics Balance Sheet

SAB Biotherapeutics's total assets for Q3 2025 were $183.45M, an increase of 508.87% from the previous quarter. SABS total liabilities were $18.37M for the fiscal quarter, a 1.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 44.20M$ 83.94M$ 50.90M$ 81.14M$ 56.54M
Total Liabilities
$ 18.23M$ 26.64M$ 19.85M$ 42.59M$ 17.53M
Total Equity Gross Minority
$ 25.97M$ 57.30M$ 31.06M$ 38.55M$ 39.01M
Other Metrics
Currency in USD

SAB Biotherapeutics Debt to Assets